Information, Expiry & Status of FDA Orange Book Patents covering Elagolix

U.S.A

ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

7176211

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2024-07-06

Patent Use Code

U-2360

Delist Requested

Application Number

210450

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

7419983

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2029-07-06

Patent Use Code

U-2360

Delist Requested

Application Number

210450

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

7176211

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2024-07-06

Patent Use Code

U-2360

Delist Requested

Application Number

210450

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

7419983

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2029-07-06

Patent Use Code

U-2360

Delist Requested

Application Number

210450

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10537572

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-09-01

Patent Use Code

U-2735

Delist Requested

Application Number

210450

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10682351

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2036-09-01

Patent Use Code

U-2850

Delist Requested

Application Number

210450

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11459305

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2028-11-07

Patent Use Code

U-2842

Delist Requested

Application Number

213388

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11344551

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2034-03-14

Patent Use Code

U-3388

Delist Requested

Application Number

210450

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11344551

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2034-03-14

Patent Use Code

U-3389

Delist Requested

Application Number

210450

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM